BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18534456)

  • 1. Venous thromboembolic disease reduction with a portable pneumatic compression device.
    Froimson MI; Murray TG; Fazekas AF
    J Arthroplasty; 2009 Feb; 24(2):310-6. PubMed ID: 18534456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
    Gelfer Y; Tavor H; Oron A; Peer A; Halperin N; Robinson D
    J Arthroplasty; 2006 Feb; 21(2):206-14. PubMed ID: 16520208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mobile compression device for thrombosis prevention in hip and knee arthroplasty.
    Colwell CW; Froimson MI; Anseth SD; Giori NJ; Hamilton WG; Barrack RL; Buehler KC; Mont MA; Padgett DE; Pulido PA; Barnes CL
    J Bone Joint Surg Am; 2014 Feb; 96(3):177-83. PubMed ID: 24500578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty.
    Edwards JZ; Pulido PA; Ezzet KA; Copp SN; Walker RH; Colwell CW
    J Arthroplasty; 2008 Dec; 23(8):1122-7. PubMed ID: 18534421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and prevention of symptomatic thromboembolic disease following unicompartmental knee arthroplasty.
    Lombardi AV; Berend KR; Tucker TL
    Orthopedics; 2007 May; 30(5 Suppl):46-8. PubMed ID: 17549868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.
    Westrich GH; Bottner F; Windsor RE; Laskin RS; Haas SB; Sculco TP
    J Arthroplasty; 2006 Sep; 21(6 Suppl 2):139-43. PubMed ID: 16950076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis.
    Levy YD; Hardwick ME; Copp SN; Rosen AS; Colwell CW
    J Arthroplasty; 2013 Mar; 28(3):474-8. PubMed ID: 23142435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolic disease after total hip and knee arthroplasty.
    Haas SB; Barrack RL; Westrich G
    Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Pensak MJ
    J Bone Joint Surg Am; 2013 Oct; 95(19):1801-11. PubMed ID: 24088973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism in thoracic and cardiovascular surgery.
    Egawa N; Hiromatsu S; Shintani Y; Kanaya K; Fukunaga S; Aoyagi S
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):505-9. PubMed ID: 19917794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
    Patel AR; Crist MK; Nemitz J; Mayerson JL
    J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery.
    Kakkos SK; Warwick D; Nicolaides AN; Stansby GP; Tsolakis IA
    J Bone Joint Surg Br; 2012 Jun; 94(6):729-34. PubMed ID: 22628585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
    Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
    Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of postoperative deep venous thrombosis in lower limb after operation by intermittent pneumatic compression].
    Lu WJ; Yu NS; Lin ZX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 May; 14(3):129-31. PubMed ID: 12080845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis of venous thromboembolism in orthopaedic surgery--trivial option, huge potential].
    Saxer F; Dick W
    Z Orthop Unfall; 2010 Jan; 148(1):26-30. PubMed ID: 20135590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.